AI-generated summary
The authors retrospectively reviewed 152 patients with locally advanced oral squamous cell carcinoma who received prophylactic photobiomodulation for radiotherapy-induced oral mucositis between 2009 and 2014. They report that overall survival and disease-free survival rates were similar to published data for conventional treatments and that PBM did not appear to affect cancer outcomes, recurrence or survival. The retrospective design limits causal conclusions.
- Participants
- 152
- Who or what was studied
- Patients with locally advanced oral squamous cell carcinoma (stage III or IV) treated with prophylactic photobiomodulation for radiotherapy-induced oral mucositis
- Limits stated in the abstract
- The study was retrospective, so it cannot establish causation, and the abstract does not report a control group or wavelengths used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Light-emitting diode. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.